fucosylated umbilical cord blood regulatory T cells
Term · Oncology and biomedicine · MLC-T-ONC-013782
Fucosylated, human umbilical cord blood (UCB)-derived regulatory T cells (Tregs), with potential immunomodulating activity. Ex vivo, Tregs are isolated from cord blood, expanded, and fucosylated. Upon infusion, the fucosylated UCB Tregs modulate immune responses and induce tolerance to allogeneic transplants, such as hematopoietic stem cell transplants (HSCTs). This suppresses graft-versus-host disease (GVHD). Fucosylation improves the activity of Tregs and reduces the amount of Tregs that need to be expanded and infused.
| Identifier | MLC-T-ONC-013782 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | fucosylated UCB Tregs |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013782",
"term": "fucosylated umbilical cord blood regulatory T cells",
"field": "Oncology and biomedicine",
"definition": "Fucosylated, human umbilical cord blood (UCB)-derived regulatory T cells (Tregs), with potential immunomodulating activity. Ex vivo, Tregs are isolated from cord blood, expanded, and fucosylated. Upon infusion, the fucosylated UCB Tregs modulate immune responses and induce tolerance to allogeneic transplants, such as hematopoietic stem cell transplants (HSCTs). This suppresses graft-versus-host disease (GVHD). Fucosylation improves the activity of Tregs and reduces the amount of Tregs that need to be expanded and infused.",
"synonyms": [
"fucosylated UCB Tregs"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fucosylated-umbilical-cord-blood-regulatory-t-cells/"
}
Record 7,627 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.